RESUMEN
Development of a rapid, on-site detection tool for snakebite is highly sought after, owing to its clinically and forensically relevant medicolegal significance. Polyvalent antivenom therapy in the management of such envenomation cases is finite due to its poor venom neutralization capabilities as well as diagnostic ramifications manifested as untoward immunological reactions. For precise molecular diagnosis of elapid venoms of the big four snakes, we have developed a lateral flow kit using a monoclonal antibody (AB1; IgG1 - κ chain; Kd: 31 nM) generated against recombinant cytotoxin-7 (rCTX-7; 7.7 kDa) protein of the elapid venom. The monoclonal antibody specifically detected the venoms of Naja naja (p < 0.0001) and Bungarus caeruleus (p<0.0001), without showing any immunoreactivity against the viperidae snakes in big four venomous snakes. The kit developed attained the limit of quantitation of 170 pg/µL and 2.1 ng/µL in spiked buffer samples and 28.7 ng/µL and 110 ng/µL in spiked serum samples for detection of N. naja and B. caeruleus venoms, respectively. This kit holds enormous potential in identification of elapid venom of the big four snakes for effective prognosis of an envenomation; as per the existing medical guidelines.
Asunto(s)
Colorimetría/métodos , Citotoxinas/análisis , Elapidae/inmunología , Inmunoensayo/métodos , Inmunotoxinas/análisis , Venenos de Serpiente/análisis , Animales , Anticuerpos Monoclonales/análisis , Anticuerpos Monoclonales/inmunología , Bungarus/genética , Bungarus/fisiología , Citotoxinas/genética , Citotoxinas/inmunología , Venenos Elapídicos/análisis , Venenos Elapídicos/genética , Venenos Elapídicos/inmunología , Elapidae/fisiología , Inmunotoxinas/genética , Inmunotoxinas/inmunología , Naja naja/inmunología , Naja naja/fisiología , Venenos de Serpiente/inmunología , Viperidae/inmunología , Viperidae/fisiologíaRESUMEN
Components of the intrinsic blood coagulation pathway, among them factor VIIIa (FVIIIa), have been recognized as suitable therapeutic targets to treat venous thromboembolism, pathological process behind two very serious cardiovascular diseases, deep vein thrombosis and pulmonary embolism. Here, we describe a unique glycoprotein from the nose-horned viper (Vipera ammodytes ammodytes [Vaa]) venom, Vaa serine proteinase homolog 1 (VaaSPH-1), structurally a serine protease but without an enzymatic activity and expressing potent anticoagulant action in human blood. We demonstrated that one of its targets in the blood coagulation system is FVIIIa of the intrinsic tenase complex, where it antagonizes the binding of FIXa. Anticoagulants with such characteristics are intensively sought, as they would be much safer for medical application as the contemporary drugs, which frequently induce excessive bleeding and other complications. VaaSPH-1 is unlikely to be orally available for chronic usage as it has molecular mass of 35 kDa. However, it represents a very promising template to design low molecular mass FVIIIa-directed anticoagulant substances, based on structural features of the interaction surface between VaaSPH-1 and FVIIIa. To this end, we constructed a three-dimensional model of VaaSPH-1 bound to FVIIIa. The model exposes the 157-loop and the preceding α-helix as the most appropriate structural elements of VaaSPH-1 to be considered as a guideline to synthesize small FVIIIa-binding molecules, potential new generation of anticoagulants.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas de Reptiles/metabolismo , Serina Proteasas/metabolismo , Tromboembolia Venosa/tratamiento farmacológico , Venenos de Víboras/metabolismo , Animales , Coagulación Sanguínea , Diseño de Fármacos , Factor VIIIa/metabolismo , Humanos , Modelos Químicos , Agregación Plaquetaria , Unión Proteica , Relación Estructura-Actividad , Viperidae/inmunologíaRESUMEN
OBJECTIVE: To design a specific polyclonal antibody against Deinagkistrodon acutus venom (DA-pAb) by immunizating New Zealand white rabbits. RESULTS: The IgG fraction was purified by affinity chromatography, and specific antibodies were purified by immunoaffinity chromatography. Polyclonal antibodies were subjected to ELISA and western blotting to evaluate their immune reactivity. We identified the mimotopes by screening a phage display 12-mer peptide library against D. acutus venom. After three rounds of biopanning with DA-pAb, 30 positive clones were identified. Eighteen phage clones were sequenced, and their corresponding amino acid sequences were deduced. Additional immunoassays with the peptides and DA-pAb identified five sequences as possible epitopes. Recombinant antigens synthesized with the five epitopes were used for the immunization of BALB/c mice. CONCLUSION: The antibodies induced by these peptides recognized the recombinant antigen and D. acutus venom and protected mice against the hemorrhagic effects of the venom.
Asunto(s)
Venenos de Crotálidos/inmunología , Epítopos/inmunología , Inmunoglobulina G/aislamiento & purificación , Viperidae/metabolismo , Secuencia de Aminoácidos , Animales , Cromatografía de Afinidad , Venenos de Crotálidos/química , Venenos de Crotálidos/genética , Epítopos/genética , Inmunización , Inmunoglobulina G/inmunología , Inmunoglobulina G/metabolismo , Masculino , Ratones , Biblioteca de Péptidos , Conejos , Análisis de Secuencia de Proteína , Viperidae/genética , Viperidae/inmunologíaRESUMEN
In the present study, we recognized progressively high immunological cross-reactivity between Pseudocerastes persicus fieldi (Pf) venom and six other medically important Egyptian snake venoms belonging to families Viperidae and Elapidae. Antibodies with a range of bonding strengths were shown to be involved in such cross-reactivity. Two strategies have been tried to access specificity; (i) using affinity purified species-specific anti-Pf antivenom antibodies, (ii) conducting the assay in the presence of ammonium thiocyanate (NH4SCN). The discrimination power of the prepared species-specific antivenom was demonstrated by its ability to detect Pf venom over a range of Pf concentrations (2.5 ng-2.5 µg) in a variety of body fluids. The assay could distinguish circulating Pf antigens from other viper antigens in the whole blood of experimentally envenomed mice. What seems promising in our work is the use of the chaotrope, NH4SCN, which renders the reaction medium more favorable for the specific homologous antigen-antibody interactions, primarily via preventing lower avid antibodies to share and, to a bit lesser extent, by decreasing non-specific absorbance signals frequently encountered with ELISA assays. The ELISA described herein may be useful for clinicians for identification of snake bites inflicted by Pf snake species. Balancing between specificity and sensitivity has to be considered for best results.
Asunto(s)
Antígenos/inmunología , Reacciones Cruzadas , Venenos de Víboras/inmunología , Viperidae/inmunología , Animales , Afinidad de Anticuerpos , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Ratones , Mordeduras de Serpientes/sangre , Mordeduras de Serpientes/inmunología , Especificidad de la Especie , Viperidae/clasificaciónRESUMEN
Snake venom protein from Deinagkistrodon acutus (DA protein), one of the major venomous species in Taiwan, causes hemorrhagic symptoms that can lead to death. Although horse-derived antivenin is a major treatment, relatively strong and detrimental side effects are seen occasionally. In our study, yolk immunoglobulin (IgY) was purified from eggs, and DA protein was recognized using Western blotting and an enzyme-linked immunosorbent assay (ELISA), similar to therapeutic horse antivenin. The ELISA also indicated that specific IgY antibodies were elicited after the fifth booster, plateaued, and lasted for at least 3 months. To generate monoclonal single-chain variable fragment (scFv) antibodies, we used phage display technology to construct two libraries with short or long linkers, containing 6.24 × 10(8) and 5.28 × 10(8) transformants, respectively. After four rounds of biopanning, the eluted phage titer increased, and the phage-based ELISA indicated that the specific clones were enriched. Nucleotide sequences of 30 individual clones expressing scFv were analyzed and classified into four groups that all specifically recognized the DA venom protein. Furthermore, based on mass spectrometry, the scFv-bound protein was deduced to be snake venom metalloproteinase proteins. Most importantly, both IgY and mixed scFv inhibited the lethal effect in mice injected with the minimum lethal dosage of the DA protein. We suggest that together, these antibodies could be applied to the development of diagnostic agents or treatments for snakebite envenomation in the future.
Asunto(s)
Proteínas de Reptiles/inmunología , Venenos de Serpiente/inmunología , Viperidae/inmunología , Secuencia de Aminoácidos , Animales , Especificidad de Anticuerpos , Embrión de Pollo , Femenino , Ratones , Ratones Endogámicos ICR , Datos de Secuencia Molecular , Proteínas de Reptiles/química , Proteínas de Reptiles/genética , Alineación de Secuencia , Anticuerpos de Cadena Única/química , Anticuerpos de Cadena Única/genética , Anticuerpos de Cadena Única/inmunología , Venenos de Serpiente/química , Venenos de Serpiente/genética , Viperidae/genéticaRESUMEN
The blood plasma of numerous snake species naturally comprises endogenous phospholipase A2 inhibitors, which primarily neutralize toxic phospholipases A2 that may eventually reach their circulation. This inhibitor type is generally known as snake blood phospholipase A2 inhibitors (sbPLIs). Most, if not all sbPLIs are oligomeric glycosylated proteins, although the carbohydrate moiety may not be essential for PLA2 inhibition in every case. The presently known sbPLIs belong to one of three structural classes namely sbPLI, sbPLI or sbPLI depending on the presence of characteristic C-type lectin-like domains, leucine-rich repeats or three-finger motifs, respectively. Currently, the most numerous inhibitors described in the literature are sbPLIs and sbPLIs, whereas sbPLIs are rare. When the target PLA2 is a Lys49 homolog or an Asp49 myotoxin, the sbPLI is denominated a myotoxin inhibitor protein (MIP). In this brief overview, the most relevant data on sbPLIs will be presented. Representative examples of sbPLIs and sbPLIs from two Old World Gloydius brevicaudus and Malayopython reticulatus and two New World Bothrops alternatus and Crotalus durissus terrificus snake species will be emphasized.
Asunto(s)
Animales , Viperidae/inmunología , Viperidae/metabolismo , Viperidae/sangre , /análisis , /químicaRESUMEN
We report the proteomic analysis of the Atlantic bushmaster, Lachesis muta rhombeata, from Brazil. Along with previous characterization of the venom proteomes of L. stenophrys (Costa Rica), L. melanocephala (Costa Rica), L. acrochorda (Colombia), and L. muta muta (Bolivia), the present study provides the first overview of the composition and distribution of venom proteins across this wide-ranging genus, and highlights the remarkable similar compositional and pharmacological profiles across Lachesis venoms. The paraspecificity of two antivenoms, produced at Instituto Vital Brazil (Brazil) and Instituto Clodomiro Picado (Costa Rica) using different conspecific taxa in the immunization mixtures, was assessed using genus-wide comparative antivenomics. This study confirms that the proteomic similarity among Lachesis sp. venoms is mirrored in their high immunological conservation across the genus. The clinical and therapeutic consequences of genus-wide venomics and antivenomics investigations of Lachesis venoms are discussed. BIOLOGICAL SIGNIFICANCE: The proteomics characterization of L. m. rhombeata venom completes the overview of Lachesis venom proteomes and confirms the remarkable toxin profile conservation across the five clades of this wide-ranging genus. Genus-wide antivenomics showed that two antivenoms, produced against L. stenophrys or L. m. rhombeata, exhibit paraspecificity towards all other congeneric venoms. Our venomics study shows that, despite the broad geographic distribution of the genus, monospecific antivenoms may achieve clinical coverage for any Lachesis sp. envenoming.
Asunto(s)
Antivenenos , Venenos de Crotálidos , Proteoma , Viperidae , Animales , Antivenenos/química , Antivenenos/genética , Antivenenos/inmunología , Venenos de Crotálidos/química , Venenos de Crotálidos/genética , Venenos de Crotálidos/inmunología , Caballos , Proteoma/química , Proteoma/genética , Proteoma/inmunología , Especificidad de la Especie , Viperidae/genética , Viperidae/inmunologíaRESUMEN
A polyspecific antivenom is used in Central America for the treatment of envenomings by viperid snakes. This antivenom is generated in horses hyperimmunized with a mixture of venoms from Bothrops asper, Crotalus simus and Lachesis stenophrys. The present study analyzed the ability of this antivenom to neutralize the venoms of three Central American viperid species of the 'Porthidium group', i.e. Porthidium nasutum, Porthidium ophryomegas and Cerrophidion sasai, formerly classified as Cerrophidion godmani. In addition, the immunorecognition of the components of these venoms was assessed by immunoaffinity antivenomics. The antivenom proved effective in neutralizing the lethal, hemorrhagic, myotoxic, phospholipase A(2) (PLA(2)) and proteinase activities of the three venoms, albeit exhibiting quantitative differences in the values of the Median Effective Doses (ED(50)). Excepting for certain low molecular mass bands corresponding to disintegrins, and some PLA(2)s and PI-metalloproteinases, Western blotting and immunoaffinity chromatography revealed immunorecognition of most Porthidium and Cerrophidion venom proteins. In agreement with in vivo neutralization assays, immobilized antivenom IgGs showed higher immunocapturing activity of toxins from both Porthidium taxa than from C. sasai. Overall our results demonstrate a significant paraspecific protection of the Costa Rican polyspecific antivenom against the three venoms sampled. They also stress the need to search for novel ways to enhance the immune response of horses against several weakly immunogenic venom components.
Asunto(s)
Antivenenos/uso terapéutico , Venenos de Crotálidos/toxicidad , Viperidae/metabolismo , Animales , Antivenenos/análisis , Antivenenos/inmunología , Cromatografía de Afinidad/métodos , Venenos de Crotálidos/química , Evaluación Preclínica de Medicamentos , Hemorragia/inducido químicamente , Hemorragia/patología , Hemorragia/prevención & control , Caballos/inmunología , Inyecciones Intraperitoneales , Dosificación Letal Mediana , Longevidad/efectos de los fármacos , Ratones , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Enfermedades Musculares/inducido químicamente , Enfermedades Musculares/patología , Enfermedades Musculares/prevención & control , Pruebas de Neutralización , Inhibidores de Fosfolipasa A2 , Proteómica/métodos , Mordeduras de Serpientes/tratamiento farmacológico , Mordeduras de Serpientes/inmunología , Viperidae/inmunologíaRESUMEN
Heparin, which was widely used thirty years ago for the treatment of viper envenomations, is now contra-indicated during the acute phase, which is at risk for hemorrhage and death. We report a case of pulmonary embolism, a rare situation in the context of viper envenomation. By means of this case report, we want to discuss the pathophysiological links between envenomation and thromboembolic disease, and on the other hand, the potential heparin usefulness, not during the acute, hemorrhagic phase, but as a prophylactic treatment when hemorrhagic risk has been replaced by an inflammatory syndrome, with increased fibrinogen and platelets which are then prothrombotic factors.
Asunto(s)
Embolia Pulmonar/etiología , Mordeduras de Serpientes/complicaciones , Animales , Antivenenos/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Marruecos , Embolia Pulmonar/diagnóstico , Embolia Pulmonar/terapia , Mordeduras de Serpientes/diagnóstico , Mordeduras de Serpientes/terapia , Venenos de Víboras/inmunología , Viperidae/inmunología , Viperidae/fisiologíaRESUMEN
One of the important aspects of species' survival is connected with global climate changes, which also conditions the epidemiology of infectious diseases. Poikilotherms are exposed, as other species, to climatic influence, especially due to their physiological peculiarities such as important stages of their life cycle: hibernation, shedding, and active phase. The immune system serves as an accurate indicator of the health status and stress levels in these species. This study aimed to monitor the changes of innate (leukocyte subpopulations and total immune globulins) and adaptive immunity (in vitro leukocyte blast transformation) of two viper species, V. berus berus and V. ammodytes ammodytes, endemic in Europe and spread in different regions of Romania during their three major life cycles, hibernation, shedding, and active phase. The results indicated that seasonal variance and cycle rather than species and regional distribution influence the functionality of the immune system.
Asunto(s)
Viperidae/inmunología , Animales , Complejo Antígeno-Anticuerpo/sangre , Cambio Climático , Hibernación , Inmunoglobulinas/sangre , Estaciones del Año , Especificidad de la Especie , Viperidae/fisiologíaRESUMEN
BACKGROUND: Guillain-Barre syndrome (GBS) is considered as an acute, immune-mediated polyradiculoneuropathy with different clinical phenotypes arising after viral or bacterial infections, vaccination or surgery. However, in 40% of GBS patients the aetiology remains unknown. In this manuscript, we report the occurrence of GBS in a patient bitten by a snake (Vipera aspis) for which a cross-reaction was shown between GM2 ganglioside and glycosidic epitopes of venom proteins. METHODS: The venom of the snake implied in the patient's envenomation was collected. Its composition was characterised by ELISA and SELDI-TOF MS. Cross-reactivities between venom proteins and GM2 gangliosides were identified by Western blot after immunoabsorption of patient's serum with increasing amounts of purified GM2. Enzymatic deglycosylation of the venom was performed to determine the specificity of the patient's serum cross-reaction. FINDINGS: We proved the absence of neurotoxicity of the viper venom. The patient's serum presented specific cross-reactions with several glycosylated venom proteins. After deglycolysation of these proteins, the patient's serum cross-reactivity was abolished. Furthermore, we compared the immune response to venom proteins of sera from two groups of patients. The first group showed IgM reactivity against GM2 ganglioside associated with GBS, and cross-reacted with venom proteins. The second group presented an IgM reactivity against CMV, without neurological disorders, and reacted with neither venom proteins nor gangliosides. INTERPRETATION: Our study proved the auto-immunological aetiology of GBS in our patient based on molecular mimicry mechanisms between venom proteins and GM2 ganglioside.
Asunto(s)
Síndrome de Guillain-Barré/etiología , Síndrome de Guillain-Barré/inmunología , Polirradiculoneuropatía/etiología , Polirradiculoneuropatía/inmunología , Mordeduras de Serpientes/etiología , Mordeduras de Serpientes/inmunología , Enfermedad Aguda , Adulto , Animales , Reacciones Cruzadas/inmunología , Síndrome de Guillain-Barré/diagnóstico , Humanos , Inmunoglobulina M/sangre , Masculino , Peso Molecular , Polirradiculoneuropatía/diagnóstico , Mordeduras de Serpientes/diagnóstico , Venenos de Víboras/sangre , Venenos de Víboras/inmunología , Venenos de Víboras/envenenamiento , Viperidae/inmunologíaRESUMEN
We conducted an extensive study of neutralization of lethality of 11 species and one subspecies of snakes of the genus Vipera, and of five species of Macrovipera, by two experimental equine antisera. One antiserum was a trivalent preparation raised against the venoms of Vipera aspis aspis, Vipera berus berus and Vipera ammodytes ammodytes; the other was a pentavalent preparation that also included venoms of Vipera (now Montivipera) xanthina and Macrovipera lebetina obtusa. We measured specific neutralization of lethality against all venoms included in the immunization schemes, and paraspecific neutralization against the venoms of Vipera ammodytes montandoni, Vipera (Montivipera) bornmuelleri, Vipera latastei, Vipera (Mo.) latifii, Vipera (Mo.) lotievi, Vipera (Daboia) palaestinae, Vipera (Mo.) raddei and Vipera seoanei, as well as against Macrovipera (D.) deserti, Macrovipera lebetina cernovi, Macrovipera lebetina turanica and Macrovipera schweitzeri. We found an important degree of paraspecific protection within each genera (omitting recent reclassification) that was quite independent of both the lethal potency of the venoms and their geographic origin. This information may be of use to clinicians charged with the treatment of Vipera or Macrovipera envenomations with non-specific antivenoms.
Asunto(s)
Antivenenos/inmunología , Sueros Inmunes/inmunología , Venenos de Víboras/inmunología , Viperidae/inmunología , Animales , Reacciones Cruzadas , Dosificación Letal Mediana , Ratones , Pruebas de Neutralización , Ratas , Ratas Wistar , Venenos de Víboras/clasificación , Viperidae/clasificaciónRESUMEN
Vipera ammodytes is the most venomous European snake, whose venom has been used as antigen for immunization of antivenom-producing animals. Same as venom of any other snake, it is a complex mixture of proteins, peptides and other compounds which biochemical and pharmacological variability has been demonstrated at interspecies and intraspecies level. In this work we demonstrated intraspecific variability between 8 venom production batches using both the conventional and the new methodology. Moreover, in contrast to the literature on different venoms' variability, for the first time we were able to select those biochemical differences that are related to and give information on the venom's toxicity and immunogenicity. We have shown that methods quantifying ammodytoxin (the most toxic compound identified so far in the Vipera ammodytes ammodytes venom) content of the venom clearly distinguish between high and low immunogenic venoms.
Asunto(s)
Antivenenos/inmunología , Fosfolipasas/inmunología , Fosfolipasas/farmacología , Venenos de Víboras/inmunología , Venenos de Víboras/toxicidad , Viperidae/inmunología , Animales , Cromatografía Líquida de Alta Presión , Ensayo de Inmunoadsorción Enzimática , Hemorragia/inducido químicamente , Dosificación Letal Mediana , Ratones , Fosfolipasas/análisis , Ratas , Ratas Endogámicas Lew , Serpientes/inmunología , Especificidad de la EspecieRESUMEN
To improve toxoid preparation, the effects of selective heat denaturation were assessed on Deinagkistrodon acutus venom. The venom and its fractions (peak 1 and peak 2 separated by gel filtration chromatography) were heated to various temperatures (45-70 degrees C) for 30 min, after which protein concentration, immunoreactivity, lethality, myotoxicity and hemorrhagic and membrane lysis activities of the samples were determined. In addition, the synergistic effects of the venom fractions were evaluated by separate or simultaneous intramuscular injection in mice. The results showed that the peak 1 fraction consisted primarily of proteins in the range of 18 to 105 kDa, while the peak 2 fraction consisted primarily of proteins smaller than 21 kDa. The hemorrhagic activity, immunoreactivity, and protein concentration of heated samples were gradually reduced as the temperature increased from 25 degrees C to 70 degrees C. Bioactivities significantly decreased but immunoreactivity was retained when the crude venom, peak 1 fraction, or peak 2 fraction were heated to the critical temperatures of 60 degrees C, 55 degrees C, or 60 degrees C, respectively. Synergistic effects of two kinds of heated fractions were observed in toxicity and antibody production after the peak 1 and peak 2 injected simultaneously or respectively. The results suggest that venom fractions heated and injected separately could significantly reduce their toxicity and enhance the neutralization of antiserum induced by them.
Asunto(s)
Venenos de Crotálidos/inmunología , Venenos de Crotálidos/toxicidad , Calor , Toxoides/inmunología , Toxoides/toxicidad , Viperidae , Animales , Anticuerpos Neutralizantes/biosíntesis , Anticuerpos Neutralizantes/inmunología , Bioensayo/métodos , Fraccionamiento Químico , Pollos , Cromatografía en Gel , Creatina Quinasa/sangre , Venenos de Crotálidos/química , Relación Dosis-Respuesta a Droga , Femenino , Cobayas , Trastornos Hemostáticos/inducido químicamente , Dosificación Letal Mediana , Masculino , Ratones , Músculo Esquelético/efectos de los fármacos , Desnaturalización Proteica , Proteínas de Reptiles/química , Proteínas de Reptiles/inmunología , Proteínas de Reptiles/toxicidad , Toxoides/química , Toxoides/farmacología , Viperidae/inmunología , Membrana Vitelina/efectos de los fármacosRESUMEN
Venoms are complex mixtures of proteins, peptides and other compounds whose biochemical and biological variability has been clearly demonstrated. These molecules have been used as antigens for immunization of anti-venom-producing animals (horses or sheep). Ammodytoxins (Atx) are potently neurotoxic compounds, and the most toxic compounds isolated so far from the Vipera ammodytes ammodytes (Vaa) venom. Recently we have shown that the level of antibodies specific to Vaa venom's most toxic component, ammodytoxin A (AtxA), (anti-AtxA IgG) in Vaa venom immunized rabbit sera highly correlated to the venom toxicity-neutralization potential of these sera. Here we investigated whether Atx content of Vaa venom could influence the outcome of immunization procedure. The novel ELISA was developed for precise determination of Atx content and Atx was quantified in venom samples used for immunization of rabbits. We clearly showed that animals immunized with the venom containing lower amount of Atx produced sera with significantly lower venom toxicity-neutralizing power and, vice versa, animals immunized with venoms containing higher amount of Atx produced sera with higher venom toxicity-neutralizing ability. Thus, the content of Atx in Vaa venom is a relevant parameter of its suitability in the production of highly protective Vaa anti-venom.
Asunto(s)
Antivenenos/inmunología , Factores Inmunológicos/inmunología , Fosfolipasas/inmunología , Venenos de Víboras/inmunología , Viperidae/inmunología , Animales , Antivenenos/farmacología , Cromatografía Líquida de Alta Presión , Ensayo de Inmunoadsorción Enzimática , Femenino , Hemorragia/inducido químicamente , Factores Inmunológicos/farmacología , Dosificación Letal Mediana , Ratones , Fosfolipasas/análisis , Fosfolipasas/farmacología , Conejos , Ratas , Ratas Endogámicas Lew , Venenos de Víboras/análisis , Venenos de Víboras/farmacologíaRESUMEN
The contribution of antibodies directed against the two main toxic groups of proteins in the Vipera ammodytes ammodytes venom, haemorrhagic metalloproteinases (H) and neurotoxic sPLA2s (Atxs), to the overall protective efficacy of the whole venom antisera was investigated. Using ELISA assays we established a high correlation between the protective efficacy of the whole venom antisera in mice and their anti-Atxs antibody content. As the haemorrhage is the prevailing toxic effect of the venom in human, the lack of correlation also with anti-H IgG content exposed that the mouse model might not be optimal to evaluate the neutralizing potential of the venom-specific antisera for human therapy. We further revealed that Atxs and structurally very similar but non-toxic AtnI2 from the venom are not immuno cross-reactive.
Asunto(s)
Antivenenos/farmacología , Sueros Inmunes/farmacología , Metaloproteasas/antagonistas & inhibidores , Fosfolipasas A2 Secretoras/antagonistas & inhibidores , Venenos de Víboras/antagonistas & inhibidores , Viperidae/inmunología , Animales , Especificidad de Anticuerpos , Antígenos , Antivenenos/inmunología , Reacciones Cruzadas , Ensayo de Inmunoadsorción Enzimática , Fosfolipasas A2 Grupo II/inmunología , Sueros Inmunes/inmunología , Inmunización , Dosificación Letal Mediana , Metaloproteasas/inmunología , Metaloproteasas/toxicidad , Ratones , Pruebas de Neutralización , Fosfolipasas A2 Secretoras/inmunología , Fosfolipasas A2 Secretoras/toxicidad , Conejos , Venenos de Víboras/enzimología , Venenos de Víboras/inmunología , Venenos de Víboras/toxicidadRESUMEN
Species-specific antibodies (Abs) to venoms from two species of the genus Echis were prepared by adsorption of monovalent and affinity purified anti-Echis Abs to the heterologous venom matrices (VMs). The avidity of the Abs to the homologous and the heterologous venoms is constantly ranked in the order; monovalent Ab>cross-reactive Ab>species-specific Ab. The avidity of the species-specific Abs to the homologous venoms of Echis coloratus (Eco) and Echis carinatus pyramidum (Epy) were 1.20+/-0.26 and 1.10+/-0.29, respectively. The avidity of the species-specific Abs to the heterologous venoms was too low to be detected. These results demonstrate for the first time that the avidity can be used to discriminate the immunologically high cross-reactive venoms. The discrimination of (14/14) venom samples of the two species on avidity bases confirmed the reliability and the specificity of the assay.
Asunto(s)
Afinidad de Anticuerpos , Venenos de Víboras/inmunología , Viperidae/clasificación , Animales , Especificidad de Anticuerpos , Reacciones Cruzadas , Ensayo de Inmunoadsorción Enzimática , Conejos , Especificidad de la Especie , Viperidae/inmunologíaRESUMEN
High titer antibodies (IgY) were raised in egg yolk of white leghorn chicken (Gallus gallus domesticus) by immunizing with the venom of Echis carinatus (Saw scaled viper or carpet viper), an Indian venomous snake belonging to the family Viperidae. The anti-snake venom antibodies (antivenom) were isolated from egg yolk by the water dilution method, enriched by 19% sodium sulfate precipitation and purified by immunoaffinity chromatography. A single, electrophoretically pure IgY band of 180-200 kDa was obtained on SDS-PAGE. Immunoblot analysis revealed not only the specific binding of the antivenom but also dose-dependent blocking of antivenom by venom proteins. In neutralization studies, a preincubated mixture of both affinity-purified (50 mg/kg body weight) as well as partially purified (210 mg/kg body weight) anti-E. carinatus IgY with 2 LD(50) dose of E. carinatus venom (2 x 6.65 mg/kg body weight) gave 100% protection in mice when administered subcutaneously.
Asunto(s)
Anticuerpos/inmunología , Anticuerpos/aislamiento & purificación , Antivenenos/inmunología , Pollos/inmunología , Yema de Huevo , Venenos de Víboras/inmunología , Viperidae/inmunología , Animales , Antivenenos/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Femenino , Immunoblotting , Inmunoglobulinas/inmunología , Dosificación Letal Mediana , RatonesRESUMEN
Macrophages play a significant role in the host defence mechanism. When activated they can produce reactive oxygen species (ROS) as well as related reactive nitrogen species (RNS). ROS are produced via NAD(P)H oxidase which catalyzes superoxide (O2-) formation. It is subsequently converted to hydrogen peroxide (H2O2) by either spontaneous or enzyme-mediated dismutation. Nitric oxide synthase (NOS) catalyzes nitric oxide (NO) formation. Canova (CA) is a Brazilian medication produced with homeopathic techniques, composed of Aconitum, Thuya, Bryonia, Arsenicum, Lachesis in distilled water containing less than 1% ethanol. Previous studies demonstrated that CA is neither toxic nor mutagenic and activates macrophages decreasing the tumor necrosis factor-alpha (TNFalpha) production. In this assay we showed that macrophages triggered with Canova increased NAD(P)H oxidase activity as well as that of iNOS, consequently producing ROS and NO respectively. Cytochrome oxidase and peroxisomes activities were inhibited by NO. As NO and O2- are being produced at the same time, formation of peroxynitrite (ONOO-) may be occurring. A potential explanation is provided on how treatment with Canova may enhance immune functions which could be particularly important in the cytotoxic actions of macrophages. CA can be considered as a new adjuvant therapeutic approach to known therapies.
Asunto(s)
Venenos de Crotálidos/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Materia Medica/farmacología , Óxido Nítrico/metabolismo , Oxidorreductasas/metabolismo , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/metabolismo , Animales , Células Cultivadas , Enfermedad de Chagas/tratamiento farmacológico , Formularios Homeopáticos como Asunto/normas , Radicales Libres/análisis , Radicales Libres/metabolismo , Histocitoquímica/métodos , Leishmania/inmunología , Leishmaniasis/tratamiento farmacológico , Macrófagos Peritoneales/enzimología , Macrófagos Peritoneales/parasitología , Macrófagos Peritoneales/ultraestructura , Masculino , Ratones , Oxidorreductasas/análisis , Factores de Tiempo , Trypanosoma cruzi/inmunología , Viperidae/inmunologíaRESUMEN
Vascular endothelial growth factors (VEGFs) are among the most important angiogenic proteins found on vertebrates. In the last years, some reports of the occurrence of such proteins in snake venoms are rising the importance of this family of proteins as toxins, since they appear to be involved in many features of Viperidae envenoming, such as hypotension and venom spread through increase in vascular permeability. Here we describe the occurrence of snake venom VEGF in Bothrops erythromelas, a clinical important snake from Northeast of Brazil, through immunodetection and cloning of its cDNA and briefly provide an overview comparison of all recent described svVEGF sequences.